Last 12 months
Inside the activity.
0 purchase rows · 202 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 39 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 42 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 10 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 20 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2016 Filed Nov 14, 2016 22:38 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,941 | $10.85 | $21,059.85 |
DisclosureSEC source: 0001179110-16-031529 · edgar.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 10:12 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 1,950 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001179110-16-030616 · edgar.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,384 Underlying: Common Stock · 1,950 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 10:12 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,950 | $10.85 | $21,157.50 |
DisclosureSEC source: 0001179110-16-030616 · edgar.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2016 Filed Sep 27, 2016 20:24 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,586 | $10.85 Strike: $10.85 | $71,458.10 |
DisclosureSEC source: 0001179110-16-030045 · edgar.xml · derivative · entry 5 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,102 Underlying: Common Stock · 6,586 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014. Read SEC document |
| September 27, 2016 Filed Sep 27, 2016 20:24 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,414 | $10.85 Strike: $10.85 | $37,041.90 |
DisclosureSEC source: 0001179110-16-030045 · edgar.xml · derivative · entry 4 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,898 Underlying: Common Stock · 3,414 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014. Read SEC document |
| September 27, 2016 Filed Sep 27, 2016 20:24 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
Exercise / conversionCommon Stock | 6,586 | $10.85 | $71,458.10 |
DisclosureSEC source: 0001179110-16-030045 · edgar.xml · nonDerivative · entry 2 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2016 Filed Sep 27, 2016 20:24 UTC |
Almstead Neil GregoryEVP Research Pharma Ops & Tech
|
Exercise / conversionCommon Stock | 3,414 | $10.85 | $37,041.90 |
DisclosureSEC source: 0001179110-16-030045 · edgar.xml · nonDerivative · entry 1 Almstead Neil Gregory · CIK 0001578850 · EVP Research Pharma Ops & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2016 Filed Sep 26, 2016 20:37 UTC |
Kovacs Shane William CharlesChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001179110-16-030032 · edgar.xml · derivative · entry 2 Kovacs Shane William Charles · CIK 0001579397 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,625 Underlying: Common Stock · 10,000 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014. Read SEC document |
| September 26, 2016 Filed Sep 26, 2016 20:37 UTC |
Kovacs Shane William CharlesChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.85 | $108,500.00 |
DisclosureSEC source: 0001179110-16-030032 · edgar.xml · nonDerivative · entry 1 Kovacs Shane William Charles · CIK 0001579397 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2016 Filed Sep 26, 2016 20:36 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionStock Option (Right To Buy) · Derivative | 2,200 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001179110-16-030031 · edgar.xml · derivative · entry 3 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,334 Underlying: Common Stock · 2,200 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. Read SEC document |
| September 26, 2016 Filed Sep 26, 2016 20:36 UTC |
Rothera MarkChief Commercial Officer
|
Exercise / conversionCommon Stock | 2,200 | $10.85 | $23,870.00 |
DisclosureSEC source: 0001179110-16-030031 · edgar.xml · nonDerivative · entry 1 Rothera Mark · CIK 0001550424 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:39 UTC |
SCHMERTZLER MICHAELDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001179110-16-030033 · edgar.xml · derivative · entry 3 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2023-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Currently exercisable. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:39 UTC |
SCHMERTZLER MICHAELDirector
|
Exercise / conversionCommon Stock | 60,000 | $10.85 | $651,000.00 |
DisclosureSEC source: 0001179110-16-030033 · edgar.xml · nonDerivative · entry 1 SCHMERTZLER MICHAEL · CIK 0001288952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 86,766 shares of common stock of the Issuer ("common stock") directly held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.